ArticleDrug, healthcare and patient safety2012

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.

Sonya Naryshkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.